Drugs / NPF-08
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03423771 | Oct 2017 → Feb 2018 | — | Nihon Pharmaceutical Co., Ltd | Completed | No outcome recorded |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT03794310 | Jan → Jun 2019 | — | Nihon Pharmaceutical Co., Ltd | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NPF-08 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03794310 ↗ |
| Route | Oral | “NPF-08 oral sulfate solution” NCT03423771 ↗ |